HALO - Halozyme Sotuvning operatsion marjasi

Halozyme Corp (HALO) kompaniyasining korporativ logotipi

Halozyme Therapeutics (HALO) kompaniyasining global ta'siri Big Pharma gigantlarining uning teri ostiga yuborish patentlariga bog'liqligiga asoslangan. Joriy operatsion marja texnologiya litsenziyalash va hamkorlar royalti to'lovlarining, shuningdek, onkologiya sohasidagi R&D muvaffaqiyatlarining samaradorligini tasdiqlaydi. 56.70 qiymati parametrning joriy holatini aks ettirib, tushumga nisbatan operatsion foyda dinamikasini namoyish etadi.

halozyme.com (HALO): Sotuvning operatsion marjasi 04.07.2022dan 20.11.2026gacha

Halozyme - tahliliy kesimlar va asosiy koʻrsatkichlar (HALO)

- bozor kapitallashuvi statistikasi:
Fundamental baholash:Halozyme Inc., HALO
halozyme.com brendining mahsuloti

Investorlar uchun reagentlar logistikasidagi geosiyosiy to'siqlar sharoitida Halozyme Therapeutics (HALO) kompaniyasining soliqlar va foizlargacha bo'lgan operatsion foyda keltirish qobiliyatini baholash orqali tegishli risklarni saralash juda muhimdir. Operatsion foyda marjasining tahlili kompaniyaning haqiqiy samaradorligini ochib beradi hamda operatsion modelning tashqi zarbalarga nisbatan fundamental kuchi va chidamliligini namoyish etib, aktivning uzoq muddatli ishonchliligini tasdiqlaydi.

Halozyme Therapeutics raqobatchilari tahlili

Operatsion rentabellik BeiGene Ltd|Operatsion rentabellik RVMD|Sotuvning operatsion marjasi AAPG (Ascentage)|Sotuvning operatsion marjasi cgoncology.com CGON|UroGen Pharma - Sotuvning operatsion marjasi|Operatsion foyda normasi BCAX|PSNL - Operatsion rentabellik|Operatsion faoliyat rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Operatsion rentabellik|Y-mAbs Therapeutics - Operatsion foyda normasi|AURA (Aura Biosciences Inc) - Operatsion marja|Sotuvning operatsion rentabelligi candeltx.com CADL|Operatsion marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Operatsion foyda normasi|Operatsion rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Operatsion rentabellik|TuHURA Biosciences Inc. - Operatsion marja|TARA - Operatsion marja|FATE (Fate Therapeutics) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Aadi Bioscience, Inc.|Sotuvning operatsion marjasi TCRX|Operatsion rentabellik CSBR|Operatsion marja XBIT|Operatsion faoliyat rentabelligi CEL-SCI Corp.|Operatsion rentabellik ostherapies.com OSTX|RADX: Operatsion foyda bo'yicha sotuv rentabelligi|ARTV: Sotuvning operatsion marjasi|ANL (Adlai Nortye) - Operatsion foyda bo'yicha sotuv rentabelligi|Veru (VERU) - Operatsion rentabellik|Sotuvning operatsion marjasi Tempest Therapeutics Inc|Operatsion rentabellik Xilio Therapeutics|Operatsion foyda bo'yicha sotuv rentabelligi RENB (Renovaro Inc.)|Operatsion rentabellik Mural Oncology PLC (MURA)|Operatsion marja Kairos Pharma (KAPA)|Operatsion rentabellik onkuretherapeutics.com OKUR|GDTC: Operatsion foyda bo'yicha sotuv rentabelligi|CRIS: Sotuvning operatsion marjasi|apollomicsinc.com (APLM) - Sotuvning operatsion marjasi|THAR: Operatsion marja|Sotuvning operatsion marjasi Advanced Biomed Inc.|Sotuvning operatsion marjasi GNPX|Operatsion foyda bo'yicha sotuv rentabelligi CLDI (Calidi Biotherapeutics)|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja